http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20887385

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 192
issn 1558-7673
issueIdentifier 2
pageRange 185-192
publicationName Clinical Genitourinary Cancer
startingPage 185
bibliographicCitation Sonpavde G, Pond GR, Rosenberg JE, Bajorin DF, Regazzi AM, Choueiri TK, Qu AQ, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Fougeray R, Dreicer R, Chen YH, Wong YN, Sridhar SS, Ko YJ, Milowsky MI, Galsky MD, Bellmunt J. Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma. Clin Genitourin Cancer. 2015 Apr;13(2):185–92. doi: 10.1016/j.clgc.2014.09.004. PMID: 25458370.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58a0cd26a2e97d3133688f12df5d9648
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4a5770583ec6a3777146cb93da0aab3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1637bbb62088def70a317ece47fc645
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0dc16b753edf47604a5b7a2d5aff5e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a12d67aec3949b17cfc331c5fbb1672
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4292-698X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb7b7d10d298acf2d0125fd8db3dfff6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ec634d14ed50ed027d1b4b90f260e33
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d49d6b1c0c8b5e3101075fb27915a95d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5a7e0f9ca3c93f62b7ca84f83a48192
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20334672392b7db731410a3562f89d66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_106a4dc3b01e4f019a7a44d92f55fd16
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11005dda5c275957caeae81cb9d4bb66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1e710d9aba3ae06053c88e840f8fb12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31b45ac1d926059b9545179907316143
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0a904fa424d266f578eaf59af1cb7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f5650424726de472671d0ef14cf931f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acea6d964074c703e7e960a53e740bdf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d9308866ec10b55f1124a4efb8758b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a1ae78c56583705583608eccf900121
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f68d247e3d57215bf54baeda27ba863e
date 201504
identifier https://doi.org/10.1016/j.clgc.2014.09.004
https://pubmed.ncbi.nlm.nih.gov/25458370
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32764
https://portal.issn.org/resource/ISSN/1558-7673
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma
discusses http://id.nlm.nih.gov/mesh/M0557421
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016879Q000379
http://id.nlm.nih.gov/mesh/D001688Q000627
http://id.nlm.nih.gov/mesh/D014571Q000188
http://id.nlm.nih.gov/mesh/D019459Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D014571Q000401
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D017322
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D014571Q000473
http://id.nlm.nih.gov/mesh/D016016
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D019459Q000187
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D018572
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173

Showing number of triples: 1 to 62 of 62.